Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration

Aging is one of the strongest risk factor for Alzheimer's disease (AD). However, several data suggest that dyslipidemia can either contribute or serve as co-factors in AD appearance. AD could be examined as a metabolic disorder mediated by peripheral insulin resistance. Insulin resistance is as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Le Stunff, Hervé, Véret, Julien, Kassis, Nadim, Denom, Jessica, Meneyrol, Kelly, Paul, Jean-Louis, Cruciani-Guglielmacci, Céline, Magnan, Christophe, Janel, Nathalie
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684947/
https://ncbi.nlm.nih.gov/pubmed/31417486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.00807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados